Inventors with similar research interests:
Location History:
- Kearny, NJ (US) (1995 - 1996)
- Jersey City, NJ (US) (2000)
- Clifton, NJ (US) (2002 - 2006)
- Montville, NJ (US) (2010 - 2024)
- Lewes, DE (US) (2022 - 2024)
Company Filing History:
13 out of 20 
12 out of 12 
10 out of 4,948 
Years Active: 1995-2025
Areas of Expertise:
**Title: Innovations by Wantanee Phuapradit: Pioneering Extended Release Compositions**
Introduction
Wantanee Phuapradit is an accomplished inventor based in Montville, NJ, known for his significant contributions to the field of pharmacology. With an impressive portfolio of 58 patents, he has been at the forefront of developing innovative drug delivery systems that enhance patient compliance and therapeutic efficacy.
Latest Patents
Among his recent inventions, Wantanee's patents cover extended release compositions consisting of pyridostigmine. These formulations are designed to maintain stable plasma concentrations while minimizing initial burst release and dose dumping. His dosage forms include matrix tablets, gastroretentive tablets, and pellets that can be conveniently dosed in capsules, tablets, or mixed with foodstuffs. The innovative methods detailed in these patents aim to improve patient adherence by offering once-a-day extended-release dosage forms of pyridostigmine bromide, ensuring superior controlled drug release. Another notable patent focuses on floating gastroretentive dosage forms that prolong gastric residence time, combined with rapidly expanding sustained release formulations for targeted drug delivery in the proximal gastrointestinal tract, ultimately maximizing therapeutic benefits.
Career Highlights
Throughout his career, Wantanee Phuapradit has collaborated with leading organizations in the pharmaceutical sector, such as Kashiv Biosciences and Amneal Complex Products Research. His extensive work experience underlines his commitment to advancing drug delivery technologies and improving patient outcomes.
Collaborations
In his professional journey, Wantanee has partnered with notable colleagues, including Navnit Hargovindas Shah and Dipen Desai. These collaborations have further enhanced the impact of his research and innovations in the field of pharmaceuticals.
Conclusion
Wantanee Phuapradit exemplifies the spirit of innovation within the pharmaceutical industry. His groundbreaking patents in extended release formulations represent a significant advancement in drug delivery systems, demonstrating the potential to improve patient adherence and therapeutic effectiveness. As he continues to push the boundaries of medical science, Wantanee remains a key figure in the evolution of pharmacological inventions.